*Refresh the page if the below document does not appear.
The Ahmedabad-based drugmaker received approval from the US regulatory authority to market Bisoprolol Fumarate and Hydrochlorothiazide tablets in multiple strengths indicated to treat Hypertension.
According to some sources, Aditya Birla Capital is in discussion to merge Birla Sun Life Insurance venture with Nippon Life, which is a 49 percent partner in Reliance Nippon Life Insurance Company (RNLIC).
In a statement, the firm stated that it has received tentative approval from the US FDA for its ANDA (Abbreviated New Drug Application) to market the Doxycycline Capsules (40mg) in the American market.
According to the latest enforcement report by the US FDA, Aurobindo Pharma USA, Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets due to Current Good Manufacturing Practices (CGMP) deviations.
Drugmaker Piramal Pharma’s Consumer Products Division (CPD) has announced the launch of its D2C Platform, Wellify.in which is a one-stop shop for all the health and wellness brand offerings by the company.
The company announced that they have received an OAI (Official Action Indicated) classification from the USFDA, this can affect the approvals pending for other products but it won’t affect the current business from the facility.
The Dhaka-based API (Active Pharmaceutical Ingredient) and Generic drugs manufacturing company declared that the Annual revenue climbed 18% to BDT34.67 Billion from BDT29.49 Billion, with the domestic sales increasing by 21% and export sales by 14%.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website